CTOs on the Move

Dungarvin

www.dungarvin.com

 
Dungarvin is a national organization of privately owned companies that are dedicated to providing high quality, community-based supports to people with varying support needs. Founded in St. Paul, Minnesota in 1976, Dungarvin has grown to employ approximately 3,500 people who currently provide supports to over 3,200 individuals across 13 states. We believe all persons faced with the challenges of a disability have the same rights and the same basic needs as do other citizens without disabilities. Dungarvin`s mission and values apply to every person we serve, including those with significant behavioral, medical and physical challenges. We are committed to principles ...
  • Number of Employees: 1K-5K
  • Annual Revenue: $100-250 Million
  • www.dungarvin.com
  • 1444 Northland Drive, Suite 100
    Mendota Heights, MN USA 55120
  • Phone: 651.699.0206
  • Fax: 651.699.0799

Executives

Name Title Contact Details

Jobs

Human Resources Director

Dungarvin Mendota Heights, MN
ungarvin has an exciting opportunity for an operational HR Director to oversee our Minnesota HR department! As a social services organization with 40 years of experience, we are seeking a results-oriented professional committed to delivering quality services for people of varying abilities and needs. Join a great team with a ...

Similar Companies

Michiana Behavioral Health Center

Michiana Behavioral Health Center is a Plymouth, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

OncoGenex

OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. have entered a global collaboration and licensing agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer and in patients with advanced, unresectable non-small cell lung cancer. Apatorsen is in Phase 2 clinical development and OGX-225 is currently in pre-clinical development.

Patient Interaction

Patient Interaction is a Bronx, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

DME Alliance

DME Alliance is a Allentown, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

The Myers Group

The Myers Group is a Duluth, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.